A Senate plan to limit insulin costs in private insurance markets is getting new life after a key committee gave it bipartisan backing.
Why it matters: Capping out-of-pocket insulin costs at $35 per month for patients with diabetes in commercial insurance has been a goal for years, but efforts have stalled over concerns about excessive government meddling.
The troubled U.S. organ donation system is set for a pivotal series of changes as administrators begin overhauling the process for deciding which organizations work with hospitals to facilitate donations.
Why it matters: More than 100,000 Americans are waiting for transplants, and the system has been dogged by patient safety concerns, instances of inappropriate conduct and conflicts of interest among organ procurement groups.
Majorities of Americans say they're more likely to vote for candidates in November who support ideas to lower their health costs, according to the latest Axios-Ipsos American Health Index.
Why it matters: Their support for ideas across the political spectrum —from renewing Affordable Care Act subsidies to expanding direct sales of prescription drugs — shows the power of voters' demands for relief.
